List of works - José I Manzano

4-Aminoquinoline-based compounds as antileishmanial agents that inhibit the energy metabolism of Leishmania

scientific article published on 05 July 2019

4-amino bis-pyridinium derivatives as novel antileishmanial agents.

scientific article published on 5 May 2014

A new ABC half-transporter in Leishmania major is involved in resistance to antimony.

scientific article published on 28 May 2013

ABCI3 Is a New Mitochondrial ABC Transporter from Leishmania major Involved in Susceptibility to Antimonials and Infectivity.

scientific article

Arylthiosemicarbazones as antileishmanial agents

scientific article published on 14 July 2016

Design, synthesis and anti-leishmanial activity of novel symmetrical bispyridinium cyclophanes.

scientific article

Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

scientific article

Identification of specific reversal agents for Leishmania ABCI4-mediated antimony resistance by flavonoid and trolox derivative screening

scientific article published on 14 October 2013

Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major

scientific article published on 3 January 2011

Leishmania LABCG1 and LABCG2 transporters are involved in virulence and oxidative stress: functional linkage with autophagy.

scientific article

Leishmania LABCG2 transporter is involved in ATP-dependent transport of thiols

scientific article

Leishmania donovani develops resistance to drug combinations

scientific article

Oxazolo[3,2-a]pyridine. A new structural scaffold for the reversal of multi-drug resistance in Leishmania

scientific article published on 10 August 2012

Tafenoquine, an antiplasmodial 8-aminoquinoline, targets leishmania respiratory complex III and induces apoptosis

scientific article published on 13 September 2010

The LABCG2 Transporter from the Protozoan Parasite Leishmania Is Involved in Antimony Resistance.

scientific article

The Oral Antimalarial Drug Tafenoquine Shows Activity against Trypanosoma brucei

scientific article

Uptake of the antileishmania drug tafenoquine follows a sterol-dependent diffusion process in Leishmania

scientific article published on 16 August 2011

List of works by José I Manzano

4-Aminoquinoline-based compounds as antileishmanial agents that inhibit the energy metabolism of Leishmania

4-amino bis-pyridinium derivatives as novel antileishmanial agents.

A new ABC half-transporter in Leishmania major is involved in resistance to antimony.

ABCI3 Is a New Mitochondrial ABC Transporter from Leishmania major Involved in Susceptibility to Antimonials and Infectivity.

Arylthiosemicarbazones as antileishmanial agents

Design, synthesis and anti-leishmanial activity of novel symmetrical bispyridinium cyclophanes.

Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

Identification of specific reversal agents for Leishmania ABCI4-mediated antimony resistance by flavonoid and trolox derivative screening

Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major

Leishmania LABCG1 and LABCG2 transporters are involved in virulence and oxidative stress: functional linkage with autophagy.

Leishmania LABCG2 transporter is involved in ATP-dependent transport of thiols

Leishmania donovani develops resistance to drug combinations

Oxazolo[3,2-a]pyridine. A new structural scaffold for the reversal of multi-drug resistance in Leishmania

Tafenoquine, an antiplasmodial 8-aminoquinoline, targets leishmania respiratory complex III and induces apoptosis

The LABCG2 Transporter from the Protozoan Parasite Leishmania Is Involved in Antimony Resistance.

The Oral Antimalarial Drug Tafenoquine Shows Activity against Trypanosoma brucei

Uptake of the antileishmania drug tafenoquine follows a sterol-dependent diffusion process in Leishmania